share_log

Recce Pharmaceuticals Ltd: R327 Efficacy against WHO Priority Pathogen Acinetobacter B

Recce Pharmaceuticals Ltd: R327 Efficacy against WHO Priority Pathogen Acinetobacter B

Recce Pharmaceuticals Ltd:R327对世界卫生组织优先级病原体Acinetobacter B有效
07/07 19:53
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息